Negev
BEER-SHEVA, ISRAEL November 24, 2009 -- Researchers at Ben-Gurion University of the Negev are developing a new device that detects cancerous skin tumors, including melanomas that aren't visible to the naked eye.
Using medication that reduces or blocks the actions of folic acid during the first trimester of pregnancy (weeks 1-12), increases the risk that the growing baby will develop abnormalities.
BEER-SHEVA, Israel, October 7, 2009 -- H2 Blocker drugs, such as Famotidine, Cimetidine and Ranitidine, approved in the U.S. for acid reflux (heartburn), pose no significant risks for the fetus according to a large collaborative cohort study by researchers at Ben-Gurion University of the Negev.
BEER-SHEVA, September, 21 2009 -- A researcher who is working on a vaccine for Alzheimer's disease (AD) has demonstrated that it is possible to test and measure specific immune responses in mice carrying human genes and to anticipate the immune response in Alzheimer's patients.
BEER-SHEVA, ISRAEL -- September 8, 2009 -- Researchers at Ben-Gurion University of the Negev have developed thin films that exhibit carrier multiplication (CM). This development is of great interest for future solar cells.
The films were synthesized at BGU by Prof.
BEER-SHEVA, ISRAEL, August 19, 2009 -- Researchers at Ben-Gurion University of the Negev are developing technology to scale up a novel method for achieving very high recoveries in desalination by reverse osmosis to be used in a Jordanian desalinization plant.
BEER-SHEVA, ISRAEL?August 14, 2009 -- Researchers at Ben-Gurion University of the Negev (BGU) will combine the scientific and scholarly expertise of their humanities and computer science experts in a new project to analyze degraded Hebrew documents.
BEER-SHEVA, ISRAEL -- July 30, 2009 -- Pregnant women have a higher incidence of insufficient amniotic fluid levels (oligohydramnios) in the summer months due to dehydration, according to a study conducted by researchers at Ben-Gurion University of the Negev (BGU).
BEER-SHEVA, ISRAEL -- July 28, 2009 -- A study conducted by researchers at Ben-Gurion University of the Negev (BGU) and John Hopkins Bloomberg School of Public Health indicates that approximately 16 percent of public health care workers will not report for work in a pandemic flu emergency, regardless of the severity.
Approximately 1 in 6 public health workers said they would not report to work during a pandemic flu emergency regardless of its severity, according to a survey led by researchers at the Johns Hopkins Bloomberg School of Public Health.
BEER-SHEVA, ISRAEL -- July 20, 2009 -- Researchers at Ben-Gurion University of the Negev (BGU) have conducted a "before and after" study of depression and terrorist attacks in adolescents, demonstrating that strong social support from friends is a buffer from depression in terrorism-related stress.
Drugs that block a growth factor receptor on brain cells may prevent epilepsy after brain damage, according to a new study appearing in the July 15 issue of the Journal of Neuroscience.
BEER-SHEVA, ISRAEL JULY, 15 2009 -- Dr. Alon Friedman, a neurosurgeon, professor and researcher at Ben-Gurion University of the Negev, working with researchers from UC Berkeley, California have identified a TGF Beta Blocker that when given to rats prevents epilepsy after brain damage, according to a new study appearing in the July 15 issue of the Journal of Neuroscience.
BEER-SHEVA, ISRAEL, July 14, 2009 -- Ben-Gurion University of the Negev (BGU) researchers, in a collaboration with colleagues from the University of Leipzig, Germany, have identified a signaling pathway that is operational in intra-abdominal fat, the fat depot that is most strongly tied to obesity-related morbidity.
BEER-SHEVA, ISRAEL, July 2, 2009 -- Researchers at Ben-Gurion University of the Negev (BGU) have discovered that gene mutations that once helped humans survive may increase the possibility for diseases, including cancer.
The findings were recently the cover story in the journal Genome Research.
The team of researchers from BGU's National Institute for Biotechnology in the Negev
